Jalota Deepika 4

4 · PMV Pharmaceuticals, Inc. · Filed Oct 3, 2024

Form 4

Period: 2024-08-13

Chief Development Officer

Transactions

Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−68,100→ 0 total
Exercise: $16.29Exp: 2033-02-10→ Common Stock (68,100 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−125,000→ 0 total
Exercise: $5.70Exp: 2033-05-12→ Common Stock (125,000 underlying)
Award
Employee Stock Option (right to buy)
2024-08-13+125,000→ 125,000 total
Exercise: $1.49Exp: 2034-03-13→ Common Stock (125,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−22,674→ 0 total
Exercise: $28.33Exp: 2031-05-11→ Common Stock (22,674 underlying)
Award
Employee Stock Option (right to buy)
2024-08-13+90,774→ 90,774 total
Exercise: $1.48Exp: 2034-08-13→ Common Stock (90,774 underlying)

Footnotes (8)

[F1]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
[F2]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 22,674 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 22,674 shares, having an exercise price of $1.48 per share.
[F3]Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
[F4]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 68,100 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 68,100 shares, having an exercise price of $1.48 per share.
[F5]One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
[F6]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
[F7]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share.
[F8]One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.

Documents

1 file